阿那莫林(Adlumiz)全网公布的2024年的最新价格

Introduction: Anamorelin (Adlumiz) is an orally available ghrelin receptor agonist. Ghrelin is a peptide mainly secreted by the stomach and an endogenous agonist of growth hormone receptor type 1a. It regulates energy metabolism in the body by promoting growth hormone secretion, increasing appetite and promoting lipogenesis. Anamorelin (Adlumiz) is a selective oral ghrelin-like agonist that acts on ghrelin receptors in the stomach. Anamorelin (Adlumiz) is thought to improve cancer cachexia by improving appetite and increasing serum insulin-like growth factor-1.

The latest price of Anamorelin (Adlumiz) in 2024 published on the entire Internet

There are original drugs and generic drugs, and the prices of different versions are different. The price of the original version of Anamorelin (Adlumiz) produced by Ono Pharmaceuticals in Japan is about 4300$-4700$ per box, and the price of the generic version of Anamorelin (Adlumiz) produced by Laos Lucius is about 3000$-3400$ per box.

The price of Anamorelin (Adlumiz) may vary depending on factors such as region, manufacturer, purchasing channel, etc. The above prices are for reference only. If you need to get the latest one, it is recommended to contact the drug supplier or regular medical institution. At the same time, you can pay attention to the official announcements of drug manufacturers or contact their customer service to obtain more accurate price information.

The reason why Anamorelin (Adlumiz) is expensive

1. Research and development costs: The research and development of Anamorelin requires huge investments, including drug discovery, preclinical research, clinical trials and other stages.

2. Production cost: The production process of biological products may involve complex biotechnology and the cost is high.

3. Market demand: Anamorelin targets specific diseases or specific patients, and the market demand may be limited, but the research and development costs need to be recovered through higher prices.

4. Medical insurance policy: Anamorelin is not included in the scope of medical insurance reimbursement, and patients need to purchase it at their own expense, which may also lead to higher drug prices.